Moderna Inc (MRNA)

$117.07 1.12 (0.97%)

16:00 EDT MRNA Stock Quote Delayed 30 Minutes

High Risk Alert: 7 Vulnerable Stocks to Dump Now

By Ian Bezek, InvestorPlace Contributor Nov 7, 2023

The economy is showing weakness. These seven stocks at risk could be at the center of the coming bust.

3 Healthcare Stocks to Invest in for a Big Shot of Gains

3 Stocks That Are Dead in the Water

Don’t Hold On: 7 Stocks to Sell Before 2024

Volume:

Previous Close -

Market Cap 44.84B

PE Ratio -7.48

EPS -15.66

Volume (Avg. Vol.) 3.43M

Day's Range $114.02 - $119.14

52-Week Range $62.55 - $170.47

Dividend & Yield N/A (N/A)

MRNA Stock Predictions, Articles, and Moderna Inc News

3 Stocks That Are Down Big, But Are Due to Fall Much Further

By Chris MacDonald, InvestorPlace Contributor Oct 12, 2023

While the search for falling stocks is an easy one, these are the ones that might not get up from the mat.

3 Shaky Stocks to Sell in October Before It’s Too Late

By Chris MacDonald, InvestorPlace Contributor Oct 9, 2023

Indeed, bearish reasons prevail. If any sort of shock hits the market, I would argue that valuations aren't positioned to absorb any sort of hit. Thus, the market is priced for basically a soft landing currently.

Don’t Miss the Boom: 3 Healthcare Stocks Set to Explode Higher

By Joel Baglole, InvestorPlace Contributor Sep 26, 2023

For these reasons, the healthcare sector is a long-term, growth opportunity for investors. In fact, all segments are forecast to experience growth over the next 15 to 20 years.

Beware! 3 Healthcare Stocks Waving Massive Red Flags Right Now.

By Alex Sirois, InvestorPlace Contributor Sep 24, 2023

These three healthcare stocks to sell are waving red flags at investors who should pay attention or suffer the consequences.

Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now

By Alex Sirois, InvestorPlace Contributor Sep 20, 2023

There are always many biotech stocks to avoid and these firms are among the clearest choices currently to steer clear of.

Beware! 3 Value Stocks Waving Massive Red Flags Right Now.

By Jeremy Flint, InvestorPlace Contributor Sep 20, 2023

Traps are omnipresent today. Don't fall for low ratios and cheap stats, but look for underlying potential. Heed these value stocks to avoid.

Beware! 3 Nasdaq Stocks Waving Massive Red Flags Right Now.

By Joel Baglole, InvestorPlace Contributor Sep 20, 2023

A range of worries are pulling these Nasdaq stocks to sell lower and clouding the outlook for their share prices.

3 Stocks to Avoid Like the Plague Right Now: MRNA, GPS, PTON

By Ian Bezek, InvestorPlace Contributor Sep 19, 2023

The good economic times of the past few years appear to be ending. As such, it's time to exit these three stocks to avoid.

The 7 Best Meme Stocks to Buy Now: September 2023

By Thomas Niel, InvestorPlace Contributor Sep 14, 2023

Let's take a look at seven past and present favorites of the Reddit set, each of which should be considered one of the best meme stocks to buy right now.

Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm

By Josh Enomoto, InvestorPlace Contributor Sep 13, 2023

Moderna released encouraging results for its late-stage trial of its flu vaccine. Now, MRNA stock is looking like more than a one-trick pony.

The 3 Most Undervalued Biotech Stocks to Buy in September 2023

By Joel Baglole, InvestorPlace Contributor Sep 12, 2023

While these undervalued biotech stocks have struggled of late, they could surprise investors and prove to be long-term winners.

3 Meme Stocks That Could Actually Rebound in Q4

By Josh Enomoto, InvestorPlace Contributor Sep 9, 2023

With meme stocks benefiting from a sector-wide resurgence, these are the compelling wagers you may want to consider.

7 Biotech Stocks to Sell in September Before They Crash & Burn

By Alex Sirois, InvestorPlace Contributor Sep 6, 2023

Biotech stocks to sell are a dime a dozen and very risky which is why September is a great time to offload them.

3 Beaten-Down Biotech Stocks Bound for a Bounce Back

By John Blankenhorn, InvestorPlace Contributor Sep 2, 2023

Biotech stocks are still below their post-pandemic peaks. But these beaten-down biotech stocks could lead the sector to new highs.

7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole

By Louis Navellier and the InvestorPlace Research Staff Aug 25, 2023

There are some solid biotech stocks on the market. But there are many more that deserve an “F” rating from the Portfolio Grader.

MRNA Stock Alert: Why Is Moderna Up 7% Today?

By Chris MacDonald, InvestorPlace Contributor Aug 17, 2023

Investors in Moderna (MRNA) stock have received a boost today from reports that a late summer Covid wave could be on the horizon.

3 Pharma Stocks to Sell in August Before They Crash and Burn

By Joel Baglole, InvestorPlace Contributor Aug 11, 2023

Stay far away from these pharma stocks that are suffering from declining sales and weak pipelines of future products.

3 Healthcare Stocks to Sell in August Before They Crash and Burn

By Joel Baglole, InvestorPlace Contributor Aug 9, 2023

Steer clear of these healthcare stocks, each of which is struggling with significant problems that are impacting their earnings.

3 ‘Strong Buy’ Biotech Stocks You Should Be Loading Up On Now

By Jeremy Flint, InvestorPlace Contributor Aug 2, 2023

Biotech stocks can be a lucrative investment opportunity, these three biotech stocks to buy now are among analyst favorites.

3 Cheap Healthcare Stocks That Smart Investors Will Snap Up Now

By Joel Baglole, InvestorPlace Contributor Aug 1, 2023

While technology stocks have powered this year's market rally, shares of healthcare companies have trailed behind. The S&P 500 Healthcare Index is essentially flat year-to-date (down 0.71%) while the benchmark S&P 500 has gained 20% on the year.

Moderna Inc (MRNA)

High Risk Alert: 7 Vulnerable Stocks to Dump Now

3 Healthcare Stocks to Invest in for a Big Shot of Gains

3 Stocks That Are Dead in the Water

Don’t Hold On: 7 Stocks to Sell Before 2024

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Moderna Inc (MRNA)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

MRNA Stock Predictions, Articles, and Moderna Inc News

Subscriber Sign in